A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
Clinical trial NCT03355820 · COMPLETED
Trial details
- NCT number
- NCT03355820
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2018-06-29
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.